Rapid risk assessment: Carbapenem-resistant Acinetobacter baumannii in healthcare settings – 8 December 2016
This risk assessment provides an overview of the epidemiological situation in Europe and describes a number of response options.
Rapid risk assessment: Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 in travellers previously hospitalised in Gran Canaria, Spain
This rapid risk assessment evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumonia e ST392 from travellers having sought medical care in Gran Canaria to healthcare facilities in their country of origin in the EU/EEA.
Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae - first update
This update of the 2016 ECDC Rapid Risk Assessment on carbapenem-resistant Enterobacteriaceae (CRE) evaluates the risk for patients and healthcare systems in EU/EEA countries due to the global spread of CRE.
Rapid risk assessment: Outbreak of carbapenemase-producing Enterobacterales in Lithuania, 2019
Between 1st February and 26th November 2019, 199 cases of Klebsiella pneumoniae carbapenemase (KPC)-producing carbapenem-resistant Enterobacterales (KPC-CRE) have been detected in Lithuania.
Communicable disease threats report, 17-23 May 2015, week 21
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 May 2015, and includes updates on Salmonella Enteritidis, influenza, Mycobacterium chimaera, Ebola virus, MERS, avian influenza and polio.
Communicable disease threats report, Week 20, 10-16 May 2015
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 May 2015, and includes updates on influenza, Salmonella Enteritidis, polio, avian influenza, Ebola virus, Mycobacterium chimaera and MERS.
- Antimicrobial resistance
- Antimicrobial Resistance and Healthcare-associated Infections Programme
- Ebola haemorrhagic fever
- Emerging and Vector-borne Diseases Programme
- Healthcare-associated infections
- Influenza in humans, seasonal
- Middle East respiratory syndrome coronavirus
- Mycobacterium chimaera
- Public health threat
- Vaccine Preventable Diseases Programme
- Western Africa
COVID-19 clusters and outbreaks in occupational settings in the EU/EEA and the UK
The aim of this document is to describe COVID-19 clusters and outbreaks in the EU/EEA and the UK linked to occupational settings, including healthcare and non-healthcare settings, and to identify possible factors contributing to transmission in these settings.
Novel coronavirus (SARS-CoV-2) - Discharge criteria for confirmed COVID-19 cases
This document suggests criteria to be considered when deciding whether a confirmed COVID-19 case can be safely (i.e. without being infectious) discharged from hospital or released from home isolation.
Options for the decontamination and reuse of respirators in the context of the COVID-19 pandemic
This document provides an overview of the evidence on the available methods for decontaminating respirators or filtering face pieces (FFP), in the event of shortages, used in healthcare settings providing care to possible, probable or confirmed COVID-19 patients.
Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer
The purpose of this risk assessment is to evaluate the risk to the citizens of Europe of CPE spread through patient mobility and to assess the effectiveness of infection control methods to stop the spread of CPE within healthcare institutions.